A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors.
Saved in:
| Title: | A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors. |
|---|---|
| Authors: | LoRusso, Patricia M.1 patricia.lorusso@yale.edu, Infante, Jeffrey R.2,3, Kim, Kevin B.4, Burris, Howard A.2,3, Curt, Gregory5, Ugochi Emeribe5, Clemett, Delyth6, Tomkinson, Helen K.6, Cohen, Roger B.7, Burris, Howard A 3rd2,3 (AUTHOR), Emeribe, Ugochi5 (AUTHOR) |
| Source: | BMC Cancer. 3/6/2017, Vol. 17, p1-13. 13p. 1 Diagram, 4 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 121674676 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22LoRusso%2C+Patricia+M%2E%22">LoRusso, Patricia M.</searchLink><relatesTo>1</relatesTo><i> patricia.lorusso@yale.edu</i><br /><searchLink fieldCode="AR" term="%22Infante%2C+Jeffrey+R%2E%22">Infante, Jeffrey R.</searchLink><relatesTo>2,3</relatesTo><br /><searchLink fieldCode="AR" term="%22Kim%2C+Kevin+B%2E%22">Kim, Kevin B.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Burris%2C+Howard+A%2E%22">Burris, Howard A.</searchLink><relatesTo>2,3</relatesTo><br /><searchLink fieldCode="AR" term="%22Curt%2C+Gregory%22">Curt, Gregory</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Ugochi+Emeribe%22">Ugochi Emeribe</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Clemett%2C+Delyth%22">Clemett, Delyth</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Tomkinson%2C+Helen+K%2E%22">Tomkinson, Helen K.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Cohen%2C+Roger+B%2E%22">Cohen, Roger B.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Burris%2C+Howard+A+3rd%22">Burris, Howard A 3rd</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Emeribe%2C+Ugochi%22">Emeribe, Ugochi</searchLink><relatesTo>5</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22BMC+Cancer%22">BMC Cancer</searchLink>. 3/6/2017, Vol. 17, p1-13. 13p. 1 Diagram, 4 Charts, 1 Graph. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=121674676 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-017-3143-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 1 Titles: – TitleFull: A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: LoRusso, Patricia M. – PersonEntity: Name: NameFull: Infante, Jeffrey R. – PersonEntity: Name: NameFull: Kim, Kevin B. – PersonEntity: Name: NameFull: Burris, Howard A. – PersonEntity: Name: NameFull: Curt, Gregory – PersonEntity: Name: NameFull: Ugochi Emeribe – PersonEntity: Name: NameFull: Clemett, Delyth – PersonEntity: Name: NameFull: Tomkinson, Helen K. – PersonEntity: Name: NameFull: Cohen, Roger B. – PersonEntity: Name: NameFull: Burris, Howard A 3rd – PersonEntity: Name: NameFull: Emeribe, Ugochi IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 03 Text: 3/6/2017 Type: published Y: 2017 Identifiers: – Type: issn-print Value: 14712407 Numbering: – Type: volume Value: 17 Titles: – TitleFull: BMC Cancer Type: main |
| ResultId | 1 |
